| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Venture Capital > What To Do If You Are Riding A Dead Horse |
|
Main Subject - What To Do If You Are Riding A Dead Horse
The lessons of the new economy hold that when you According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product discover that you are riding a
dead horse, the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in best strategy is to get off and rapidly find a ne lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. w mount. However, in
traditional business, it is here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe often difficult to let go of your investment in d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ead horses,
which leads you to try other strateg ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ies to breach life into hopeless investments, suc easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi h
as: * Change riders * Buy a stronger whip * nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Harness several dead horses together for increas and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ed speed * Emulate the best practices of compani ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s riding dead horses * Outsource the ridership o ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a f the horse * Affirm, “This is the way we have a dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lways ridden this horse.” * Change the requireme cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nts, declaring, “This horse is not dead.” * Perf tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen orm a cost analysis to see if contractors can rid t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel it cheaper. * Promote the dead horse to a manag ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ement position. * Have the solicitors bring suit y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products against the horse manufacturer. * Put out a new . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s release that, in the unlikely event the horse i elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s dead, it was dead before it came to the company tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Energy Savings by Use of the Correct Spray Nozzle Medical Transcription Salary Outlook Customer Service for Vitamin Stores
|